Out of 694, the Global Startup Heat Map highlights 5 Top Pathology Startups
Startups such as the examples highlighted in this report focus on interactive tissue segmentation, clinical decision support, automated cancer reporting, and real-time image analysis. While all of these technologies play a significant role in advancing healthcare, they only represent the tip of the iceberg. This time, you get to discover five hand-picked pathology startups.
The Global Startup Heat Map below reveals the geographical distribution of 694 exemplary startups & scaleups we analyzed for this research. Further, it highlights five healthcare startups that we hand-picked based on scouting criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 689 pathology startups, get in touch with us.
Deciphex offers Interactive Tissue Segmentation
Founding Year: 2017
Location: Dublin, Ireland
Funding: USD 20 M
Partner with Deciphex for Digital Pathology Software
Irish startup Deciphex develops Patholytix, an artificial intelligence (AI)-integrated digital pathology platform. It supports interactive tissue segmentation to identify and quantify feature-specific morphology and orientation of samples. The platform also detects signs of drug toxicity in preclinical safety assessment studies and infers toxicologic pathology outcomes. Besides, it follows a good laboratory practice (GLP)-compliant workflow. Further, Deciphex provides on-demand collaboration between remote pharma and contract research organization partners.
Crosscope provides Clinical Decision Support
Founding Year: 2019
Location: Mountain View, US
Funding: USD 120 000
Collaborate with Crosscope for AI-based Stained Slide Analysis
US-based startup Crosscope makes an AI and deep learning-based telepathology platform. It offers clinical decision support to automate cancer image analysis. The startup’s proprietary open digital pathology solution, Crosscope Dx, utilizes neural networks and deep learning. The startup’s other product, Orion AI, aids pathologists in making diagnostic decisions and cancer analysis. Lastly, Crossscope’s Scope H&E AI allows pathologists and researchers to calculate the morphometric features to identify and quantify nuclei with H&E stained slides.
Gestalt Diagnostics enables Automated Cancer Reporting
Founding Year: 2017
Location: Spokane, US
Funding: USD 4,6 M
Work with Gestalt Diagnostics for Integrated Radiology Management
US-based startup Gestalt Diagnostics develops a series of products for cancer diagnosis. The startup’s radiology picture archiving and communication system (PACS)-image management system, Pathflow, supports digital and glass slide configurations. Its other solution, Artificial Intelligence Requisition Engine (AIRE), features an intuitive and continual learning AI algorithm. It allows pathologists to validate patient information against an existing database to reduce manual errors. Gestalt Diagnostics further develops a solution that allows clinical and pathological laboratories to meet regulatory requirements and report cancers.
Augmentiqs advances Real-Time Pathology Image Analysis
Founding Year: 2016
Location: Haifa, Israel
Funding: USD 100 000
Reach out to Augmentiqs for Microscope-based Digital Pathology
Israeli startup Augmentiqs provides an integrated imaging system. The startup’s technology combines real-time imaging, digital pathology software, and an eyepiece display within the microscope. It enables pathologists to access digital pathology applications from the microscope and connect with remote colleagues through real-time telepathology.
Aignostics provides Pathological Tissue Analysis
Founding Year: 2018
Location: Berlin, Germany
Funding: USD 5,8 M
Use Aignostics’ solution for Novel Disease Biomarker Discovery
German startup Aignostics offers end-to-end prediction models based on pathological tissue analysis. The startup’s proprietary platform advances tissue segmentation, cell detection, and classification. It also features predictive analytic models to analyze molecular and clinical parameters. Aignostics’s patented AI does layer-wise relevance propagation to reverse-engineer the black-box image models. It then predicts molecular and clinical parameters and uncovers novel biomarkers. This way, the startup facilitates clinical routine analysis as well as pre-clinical and translational research.
Where is this Data from & how to Discover More Healthcare Startups?
Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. The insights of this data-driven analysis are derived from our Big Data & AI-powered StartUs Insights Discovery Platform, covering 2 500 000+ startups & scaleups globally.
The platform gives you an exhaustive overview of emerging technologies & lets you scout relevant startups within a specific field in just a few clicks. To explore healthcare technologies in more detail, let us look into your areas of interest. For a more general overview, download our free Healthcare Innovation Report to save your time and improve strategic decision-making.
